Paraffin embedded tumor tissues, obtained from SCLC patients who had no evidence of paraneoplastic autoimmune degeneration, were evaluated for SOX2 expression by immunohistochemistry for both intensity and extent of staining.
Between January 2005 and 2006 all patients admitted to Hepatology outpatient unit with elevated liver function tests, no alcohol history, no drug usage, with negative viral hepatitis and autoimmune serology were further evaluated for NAFLD.
However, the specificity of these biomarkers has not been evaluated for CTD-ILD, UCTD, lung dominant CTD, and autoimmune-featured ILD.
Beyond its approval, rituximab is being used and/or evaluated for further disease entities like immune thrombocytopenia [ 5], autoimmune hemolytic disease [ 6], posttransplant lymphoproliferative disorders [ 7] and multiple sclerosis [ 8].
People with unexplained fatigue, fever or muscle pain, or acute change in emotional or cognitive function, or with a diagnosis of autoimmune or degenerative neurological disease, should be evaluated for Lyme.
All patients who received ≥1 dose of abatacept were evaluated for safety, including AEs, serious AEs (SAEs), and events of clinical interest (i.e., serious infections, malignancies, autoimmune events, and injection site reactions).
A series of tetrahydroisoquinoline derivatives were designed, synthesized, and evaluated for their potential as novel orally efficacious retinoic acid receptor-related orphan receptor-gamma t (RORγt) inverse agonists for the treatment of Th17-driven autoimmune diseases.
Data were evaluated for normality.
From clinical point of view, serum leptin levels have been evaluated in several autoimmune conditions.
Pro-inflammatory cytokines, such as TNF or IL12A, the T-cell activation molecule CD28, the regulatory molecules IL10, TGFB1 or the adhesion molecules ITGA4 and ITGB1 have all been evaluated previously as therapeutic targets for autoimmune diseases, including MS [24] [29].
